In today’s market, speed to market isn’t just a competitive advantage – it’s a patient imperative. Every day a new therapy is delayed results in lost revenue, operational uncertainty and most importantly, patients left waiting for treatment.
This playbook explores how Cardinal Health helps biopharmaceutical manufacturers overcome launch complexities and deliver therapies to patients as soon as one week after FDA approval.
Learn how aligning packaging and 3PL services under one enterprise unlocks speed, reduces risk and enables a smoother, more efficient path to market.
Inside, you’ll find actionable insights on:
- Building a 24-month pre-PDUFA roadmap
- Best practices for integrated packaging and 3PL planning
- The 7-day post-approval execution timeline
- What to look for in a commercialization partner
Whether you’re planning your first launch or refining your go-to-market strategy, this guide helps you stay ahead of the clock – and focused on the patients who need your therapy.